Top 10 Healthcare Devices and Supplies Capital Raises and Investors in the U.S. – June 1st to 30th, 2026
Several interesting transactions closed in the Healthcare Devices and Supplies sector over the past month. If you would like more info or would like to discuss the capital raising market for your company, please contact me.
PE Growth/Expansion
- Emblok, embolic protection system that offers protection from material released during left-sided cardiovascular procedures, received $6 million of development capital.
- Spineology, spinal implants that provide relief for patients suffering from spinal cord pain, received $12.64 million of development capital.
Merger/Acquisition
- Cellmyx, proprietary medical technology products and medical devices for the harvesting, processing, and deployment of autologous soft tissue, was acquired by Micro Identification Technologies.
- Scientia Vascular, endovascular medical devices for neuro, peripheral, and coronary vascular access applications, was acquired by Medtronic for $550 million.
Later Stage VC
- Ceek Women’s Health, medical devices that transform the delivery of gynecological care for women, raised $7 million of Series A1 venture funding from investors, putting the company’s pre-money valuation at $69 million.
- Nuclein, rapid PCR testing system that delivers lab results at the point of care, raised $20.36 million of venture funding in the form of convertible debt.
Early Stage VC
- Restora, restorative sleep apnea therapy that treats obstructive sleep apnea, raised $11.5 million of Series A-2 venture funding from investors, putting the company’s pre-money valuation at $37.5 million.
- SterileState, sterilization technology that provides efficient sterilization methods, raised $10.78 million of venture funding.
Seed Round
- Carna Health, advanced kidney health technology platform that helps in the early detection and management of kidney disease, raised $9.07 million of seed funding.
- StrideLink, wearable device that connects healthcare providers with essential data, raised $1.49 million through a combination of Seed funding from Dorm Room Fund, GTF Ventures, and other investors, putting the company’s pre-money valuation at $10.51 million.
#castleplacement #capitalraising #privateequity #venturecapital #investment #healthcare #medtech #medicaltechnology #healthcaredevices #healthcaresupplies
Tamara Williams
Managing Director
Please contact me if you have any questions or would like to discuss your capital raise:
Email: twilliams@castleplacement.com
(C) (385) 600-1871
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
